Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Eli Lilly and Company (LLY)

81.37 +0.41 (+0.51%)

4/27/2017  12:27pm

Open:

80.97

Pre. Close:

80.96

High:

81.49

Low:

80.69

Volume:

1,741,828

Market Cap:

85.51B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

82.08 - 82.58

82.58 - 82.93

Low:

79.89 - 80.41

80.41 - 80.75

Close:

80.22 - 81.11

81.11 - 81.7

Technical analysis  (as of: 2017-04-27 11:57:52 AM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 98.24     One year: 101.29

Support:

Support1: 79.88    Support2: 66.46

Resistance:

Resistance1: 84.11    Resistance2: 86.72

Pivot:

83.28

Moving Averages:

MA(5): 81.71     MA(20): 83.71

MA(100): 78.62     MA(250): 77.24

MACD:

MACD(12,26): -0.64     Signal(12,26,9): -0.19

%K %D:

%K(14,3): 17.99     %D(3): 26.81

RSI:

RSI(14): 39.81

52-Week:

High: 86.72  Low: 64.18  Change(%): 10.2

Average Vol(K):

3-Month: 3792  10-Days 5453

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
LLY has closed above bottom band by 23.8%. Bollinger Bands are 32.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 25 Apr 2017 10:54:19 GMT
Lilly gives no time frame on arthritis drug delay; shares fall

Tue, 25 Apr 2017 12:00:00 GMT
Demand for newer drugs boosts Eli Lilly

Wed, 26 Apr 2017 06:22:30 GMT
Eli Lilly & Co. (LLY) Q1 2017 Results - Earnings Call Transcript

Tue, 25 Apr 2017 10:30:00 GMT
Eli Lilly And Co. Announces 18% Increase In Q1 Profit

Tue, 25 Apr 2017 12:11:15 GMT
The Coca-Cola Co Misses On Earnings, Eli Lilly And Co Beats Estimates

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

1050.00

Shares Float (M)

923.58

% Held by Insiders

11.81

% Held by Institutions

65.90

Shares Short (K)

9350

Shares Short Prior Month (K)

12150

Stock Financials

EPS

2.580

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

13.330

PEG Ratio

1.60

Profit Margin

12.90

Operating Margin

18.24

Return on Assets (ttm)

6.5

Return on Equity (ttm)

19.1

Qtrly Rev. Growth

7.2

Gross Profit (p.s.)

14.829

Sales Per Share

20.210

EBITDA (p.s.)

5.114

Qtrly Earnings Growth

61.30

Operating Cash Flow (M)

4850.00

Levered Free Cash Flow (M)

2850.00

FoxReading.com

Valuation

P/E

31.43

P/E Growth Ratio

P/BV

6.08

P/S

4.01

P/CF

17.56

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2017-03-10

Ex-Dividend Date

2017-02-13

Forward Dividend

2.080

Last Split Date

Last Split Ratio

2

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.